Siegfried Holding AG - Company Profile
Powered by 
All the sales intelligence you need on Siegfried Holding AG in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Siegfried Holding AG fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Siegfried Holding AG.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Siegfried Holding AG’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Siegfried Holding AG's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Martin Schmid
Vice Chairman Executive BoardMr Martin Schmid has been the Director and Vice Chairman of the company since 2016. Prior to this, he served as the Director at Swiss Life Holding AG. Previously, he served as the Chairman and Director at EKW AG and ELIN AG. He served as the Director at Swissgas AG and Calanda Holding AG.
Marcel Imwinkelried
Chief Operating Officer - Drug Products and Interim; Chief Executive Officer Senior ManagementMr. Marcel Imwinkelried has been the Chief Executive Officer and Chief Operating Officer of Drug Products and Interim for the company since 2024. Prior to this, he served as the Chief Operating Officer of Drug Products and as Multi-Site Head for the Drug Products sites in Barbera del Valles and El Masnou (Spain), and Irvine (California) of the company. He has also served as Global Head of Technical Operations, Solids at Novartis.
Reto Suter
Chief Financial Officer Senior ManagementMr. Reto Suter has been the Chief Financial Officer of the company since 2017. Prior to this, he served as the Chief Operating Officer, Chief Information Officer and Board Member at Lonrho.
Stefan Randl
Chief Scientific Officer Senior ManagementMr. Stefan Randl has been the Chief Scientific Officer of the company since January 2025. Prior to this, he served as the Vice President of Innovation Management, Health Care at Evonik. Previously, he served as the Vice President of the Drug Substance at Evonik. He also served as Head of Sales & Services for Health Care in Asia at Evonik.
Luca Dalla Torre
Chief Legal and Sustainability Officer Senior ManagementMr. Luca Dalla Torre has been the Chief Legal and Sustainability Officer of the company since January 2025. Prior to this, he served as General Counsel of the company.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer